Multidrug resistance-associated protein (MRP) expression is correlated with expression of aberrant p53 protein in colorectal cancer

European Journal of Cancer

Volumn 35, Issue 6, 1999, Pages 935-938

  Fukushima, Y ^a   Oshika, Y ^a   Tokunaga, T ^a   Hatanaka, H ^a   Tomisawa, M ^a   Kawai, K ^a   Ozeki, Y ^b   Tsuchida, T ^a   Kijima, H ^a   Yamazaki, H ^a   Ueyama, Y ^a   Tamaoki, N ^a   Miura, S ^b   Nakamura, M ^a  

^a TOKAI UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^b NATIONAL DEFENSE MEDICAL COLLEGE   (Japan)

Author keywords

Carcinoma in adenoma (CIA); Coexpression; Colorectal cancer (CRC); Multidrug resistance associated protein (MRP); P53

Indexed keywords

MULTIDRUG RESISTANCE PROTEIN; PROTEIN P53;

ADULT; ARTICLE; CARCINOMA IN SITU; COLON ADENOMA; COLON POLYP; COLORECTAL CANCER; CONTROLLED STUDY; FEMALE; HUMAN; HUMAN TISSUE; MALE; MULTIDRUG RESISTANCE; PRIORITY JOURNAL; PROTEIN EXPRESSION; RECTUM ADENOMA; RECTUM POLYP;

ADENOMA; ADENOMATOUS POLYPOSIS COLI; ATP-BINDING CASSETTE TRANSPORTERS; COLORECTAL NEOPLASMS; DRUG RESISTANCE, NEOPLASM; FEMALE; GENE EXPRESSION; HUMANS; IMMUNOHISTOCHEMISTRY; MALE; MIDDLE AGED; MULTIDRUG RESISTANCE-ASSOCIATED PROTEINS; NEOPLASM PROTEINS; TUMOR SUPPRESSOR PROTEIN P53;

EID: 0033152871     PISSN: 09598049     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0959-8049(99)00035-0     Document Type: Article

References (28)

1. Fojo A.T., Whang-Peng J., Gottesman M.M., Pastan I. Amplification of DNA sequences in human multidrug-resistant KB carcinoma cells. Proc Natl Acad Sci USA. 82:1985;7661-7665.
2. Gros P., Neriah Y.B., Croop J.M., Housman D.E. Isolation and expression of a complementary DNA that confers multidrug resistance. Nature. 323:1986;728-731.
3. Giaccone G., Gazdar A.F., Beck H., Zunino F., Capranico G. Multidrug sensitivity phenotype of human lung cancer cells associated with topoisomerase II expression. Cancer Res. 52:1992;1666-1674.
4. Cole S.P.C., Bhardwaj G., Gerlach J.H.et al. Overexpression of a transporter gene in a multidrug-resistant human lung cancer cell line. Science. 258:1992;1650-1654.
5. Grant C.E., Valdimarsson G., Hipfner D.R., Almquist K.C., Cole S.P.C., Deeley R.G. Overexpression of multidrug resistance-associated protein (MRP) increases resistance to natural product drugs. Cancer Res. 54:1994;357-361.
6. Loe D.W., Deeley R.G., Cole S.P. Biology of the multidrug resistance-associated protein, MRP. Eur J Cancer. 32:1996;945-957.
7. Nooter K., Westerman A.M., Flens M.et al. Expression of multidrug resistance-associated protein (MRP) gene in human cancers. Clini Cancer Res. 1:1995;1301-1310.
8. Ota E., Abe Y., Oshika Y.et al. Expression of the multidrug resistance-associated protein (MRP) gene in non-small-cell lung cancer. Br J Cancer. 72:1995;550-554.
9. Nooter K., Bosman F.T., Burger H.et al. Expression of the multidrug resistance-associated protein (MRP) gene in primary non-small-cell lung cancer. Ann Oncol. 7:1996;75-81.
10. Sugawara I., Arai T., Yamashita T., Yoshida A., Masunaga A., Itoyama S. Expression of multidrug resistance-associated protein (MRP) in anaplastic carcinoma of the thyroid. Cancer Lett. 82:1994;185-188.
11. Abe T., Hasegawa S., Taniguchi K.et al. Possible involvement of multidrug-resistance-associated protein (MRP) gene expression in spontaneous drug resistance to vincristine, etoposide and adriamycin in human glioma cells. Int J Cancer. 58:1994;860-864.
12. Takebayashi Y., Akiyama S., Natsugoe S.et al. The expression of multidrug resistance protein in human gastrointestinal tract carcinomas. Cancer. 82:1998;661-666.
13. Endo K., Maehara Y., Ichiyoshi Y.et al. Multidrug resistance-associated protein expression in clinical gastric carcinoma. Cancer. 77:1996;1681-1687.
14. Chin K.V., Ueda K., Pastan I., Gottesman M.M. Modulation of activity of the promoter of the human MDR1 gene by ras and p53. Science. 255:1992;459-462.
15. Casey G., Lopez M.E., Ramos J.C.et al. DNA sequence analysis of exon 2 through 11 and immunohistochemical staining are required to detect all known p53 alterations in human malignancies. Oncogene. 13:1996;1971-1981.
16. Oshika Y., Nakamura M., Tokunaga T.et al. Multidrug resistance-associated protein (MRP) and mutant p53 protein expression in non-small cell lung cancer. Mod Pathol. 11:1998;1059-1063.
17. Morson BC, Dawson IMP, Day DW, Jass JR, Price AB, Williams GT. Morson and Dawson's Gastrointestinal Pathology, 3rd ed. Oxford, Blackwell, 1990.
18. Fenoglio-Preiser CM, Pascal RR, Perzin KH. Tumor of the Intestines. Washington, Armed Forces Institute of Pathology, 1990.
19. Sobin LH, Whittekind Ch, TNM classification of malignant tumours fifth edn. New York Wiley-Liss 1997.
20. Abe Y., Yamazaki H., Oshika Y.et al. Advantage of in vivo chemosensitivity assay to detect vincristine-resistance in the human tumor xenograft. Anticancer Res. 16:1996;729-734.
21. Tomonaga M., Oka M., Narasaki F.et al. The multidrug resistance-associated protein gene confers drug resistance in human gastric and colon cancers. Jpn J Cancer Res. 87:1996;1263-1270.
22. Ciaccio P.J., Shen H., Kruh G.D., Tew K.D. Effects of chronic ethacrynic acid exposure on glutathione conjugation and MRP expression in human colon tumor cells. Biochem Biophys Res Commun. 222:1996;111-115.
23. Fearon E.R., Vogelstein B. A genetic model for colorectal tumorigenesis. Cell. 61:1990;759-767.
24. Ohue M., Tomita N., Monden T.et al. A frequent alteration of p53 gene in carcinoma in adenoma of colon. Cancer Res. 54:1994;4798-4804.
25. Papatheodoridis G.V., Kapranos N., Tzouvala M., Triantafyllou K., Elemenoglou I., Karamanolis D.G. p53 and bcl-2 protein expression in rectosigmoid adenomas. Am J Gastroenterol. 93:1998;1136-1140.
26. Tollenaar R.A., van Krieken J.H., van Slooten H.J.et al. Immunohistochemical detection of p53 and Bcl-2 in colorectal carcinoma: no evidence for prognostic significance. Br J Cancer. 77:1998;1842-1847.
27. Barletta A., Marzullo F., Pellecchia A.et al. DNA flow cytometry, p53 levels and proliferative cell nuclear antigen in human colon dysplastic, precancerous and cancerous tissues. Anticancer Res. 18:1998;1677-1682.
28. Fillpits M., Suchomel R.W., Dekan G.et al. Expression of the multidrug resistance-associated protein (MRP) gene in colorectal carcinomas. Br J Cancer. 75:1997;208-212.